Photo by sxy_selia from unsplash
Multiple sclerosis (MS) patients treated with interferon beta (IFNβ) are at risk of a declining response to treatment because of the production of IFNβ‐neutralizing antibodies (NAbs). The expression of Myxovirus… Click to show full abstract
Multiple sclerosis (MS) patients treated with interferon beta (IFNβ) are at risk of a declining response to treatment because of the production of IFNβ‐neutralizing antibodies (NAbs). The expression of Myxovirus resistance protein A (MxA) mRNA is regarded as a marker of IFNβ bioactivity.
Keywords:
preceding nab;
mxa mrna;
ifn;
decrease preceding;
mrna decrease;
nab detection
Journal Title: Brain and Behavior
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Brain and Behavior
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!